{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:44Z","timestamp":1792783124780,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82103507"],"award-info":[{"award-number":["82103507"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05701-z","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:38:13Z","timestamp":1787906293000},"page":"5009-5026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liensinine-loaded extracellular vesicles mitigate osteoporosis through inhibition of NF-\u03baB signaling and calcium oscillations in osteoclasts"],"prefix":"10.1007","volume":"481","author":[{"given":"Yiwei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maihuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1604-330X","authenticated-orcid":false,"given":"Zhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"5701_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature01660","volume":"423","author":"S Harada","year":"2003","unstructured":"Harada S, Rodan GA (2003) Control of osteoblast function and regulation of bone mass. Nature 423:349\u2013355. https:\/\/doi.org\/10.1038\/nature01660","journal-title":"Nature"},{"key":"5701_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","volume":"11","author":"TJ Martin","year":"2005","unstructured":"Martin TJ, Sims NA (2005) Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11:76\u201381. https:\/\/doi.org\/10.1016\/j.molmed.2004.12.004","journal-title":"Trends Mol Med"},{"key":"5701_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev.pathmechdis.3.121806.151431","volume":"3","author":"DV Novack","year":"2008","unstructured":"Novack DV, Teitelbaum SL (2008) The Osteoclast: Friend or Foe? Annu Rev Pathol Mech Dis 3:457\u2013484. https:\/\/doi.org\/10.1146\/annurev.pathmechdis.3.121806.151431","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"5701_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s12276-024-01157-7","volume":"56","author":"N Takegahara","year":"2024","unstructured":"Takegahara N, Kim H, Choi Y (2024) Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases. Exp Mol Med 56:264\u2013272. https:\/\/doi.org\/10.1038\/s12276-024-01157-7","journal-title":"Exp Mol Med"},{"key":"5701_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.657","author":"Z Wu","year":"2024","unstructured":"Wu Z, Li W, Jiang K et al (2024) Regulation of bone homeostasis: signaling pathways and therapeutic targets. MedComm. https:\/\/doi.org\/10.1002\/mco2.657","journal-title":"MedComm"},{"key":"5701_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115772","volume":"24","author":"IV Zhivodernikov","year":"2023","unstructured":"Zhivodernikov IV, Kirichenko TV, Markina YV et al (2023) Molecular and cellular mechanisms of osteoporosis. IJMS 24:15772. https:\/\/doi.org\/10.3390\/ijms242115772","journal-title":"IJMS"},{"key":"5701_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.244","volume":"4","author":"H Wang","year":"2023","unstructured":"Wang H, Luo Y, Wang H et al (2023) Mechanistic advances in osteoporosis and anti-osteoporosis therapies. MedComm (Beijing) 4:e244. https:\/\/doi.org\/10.1002\/mco2.244","journal-title":"MedComm (Beijing)"},{"key":"5701_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.beem.2008.06.001","volume":"22","author":"C Holroyd","year":"2008","unstructured":"Holroyd C, Cooper C, Dennison E (2008) Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab 22:671\u2013685. https:\/\/doi.org\/10.1016\/j.beem.2008.06.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"5701_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108168","volume":"237","author":"S Song","year":"2022","unstructured":"Song S, Guo Y, Yang Y, Fu D (2022) Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Ther 237:108168. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108168","journal-title":"Pharmacol Ther"},{"key":"5701_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165685","volume":"21","author":"J Kodama","year":"2020","unstructured":"Kodama J, Kaito T (2020) Osteoclast multinucleation: review of current literature. Int J Mol Sci 21:5685. https:\/\/doi.org\/10.3390\/ijms21165685","journal-title":"Int J Mol Sci"},{"key":"5701_CR11","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum SL (2000) Bone Resorption by Osteoclasts. Science 289:1504\u20131508. https:\/\/doi.org\/10.1126\/science.289.5484.1504","journal-title":"Science"},{"key":"5701_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4248\/BR201301003","volume":"1","author":"F Xu","year":"2013","unstructured":"Xu F, Teitelbaum SL (2013) Osteoclasts: New Insights. Bone Res 1:11\u201326. https:\/\/doi.org\/10.4248\/BR201301003","journal-title":"Bone Res"},{"key":"5701_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1196\/annals.1402.071","volume":"1116","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H (2007) The Role of NFAT in Osteoclast Formation. Ann N Y Acad Sci 1116:227\u2013237. https:\/\/doi.org\/10.1196\/annals.1402.071","journal-title":"Ann N Y Acad Sci"},{"key":"5701_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL\u2013RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17\u201325. https:\/\/doi.org\/10.1016\/j.molmed.2005.11.007","journal-title":"Trends Mol Med"},{"key":"5701_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342. https:\/\/doi.org\/10.1038\/nature01658","journal-title":"Nature"},{"key":"5701_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1210\/me.2007-0237","volume":"22","author":"K Kim","year":"2008","unstructured":"Kim K, Lee S-H, Ha Kim J et al (2008) NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP). Mol Endocrinol 22:176\u2013185. https:\/\/doi.org\/10.1210\/me.2007-0237","journal-title":"Mol Endocrinol"},{"key":"5701_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20:200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z","journal-title":"Nat Rev Drug Discov"},{"key":"5701_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s13237-022-00405-3","volume":"65","author":"N Nasim","year":"2022","unstructured":"Nasim N, Sandeep IS, Mohanty S (2022) Plant-derived natural products for drug discovery: current approaches and prospects. Nucleus 65:399\u2013411. https:\/\/doi.org\/10.1007\/s13237-022-00405-3","journal-title":"Nucleus"},{"key":"5701_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/pca.2517","volume":"25","author":"Z Lin","year":"2014","unstructured":"Lin Z, Yang R, Guan Z et al (2014) UPLC Separation and QTof\u2013MS Identification of Major Alkaloids in Plumula Nelumbinis. Phytochem Anal 25:485\u2013494. https:\/\/doi.org\/10.1002\/pca.2517","journal-title":"Phytochem Anal"},{"key":"5701_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111335","volume":"127","author":"G Wang","year":"2024","unstructured":"Wang G, Ma F, Xie K et al (2024) Liensinine alleviates mouse intestinal injury induced by sepsis through inhibition of oxidative stress, inflammation, and cell apoptosis. Int Immunopharmacol 127:111335. https:\/\/doi.org\/10.1016\/j.intimp.2023.111335","journal-title":"Int Immunopharmacol"},{"key":"5701_CR21","doi-asserted-by":"publisher","first-page":"8245614","DOI":"10.1155\/2022\/8245614","volume":"2022","author":"F Jia","year":"2022","unstructured":"Jia F, Liu Y, Dou X et al (2022) Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2\/STAT3 Signaling Pathway. Oxid Med Cell Longev 2022:8245614. https:\/\/doi.org\/10.1155\/2022\/8245614","journal-title":"Oxid Med Cell Longev"},{"key":"5701_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110563","volume":"122","author":"W Zhang","year":"2023","unstructured":"Zhang W, Chen H, Xu Z et al (2023) Liensinine pretreatment reduces inflammation, oxidative stress, apoptosis, and autophagy to alleviate sepsis acute kidney injury. Int Immunopharmacol 122:110563. https:\/\/doi.org\/10.1016\/j.intimp.2023.110563","journal-title":"Int Immunopharmacol"},{"key":"5701_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111030","volume":"396","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yuan S, Fan H et al (2024) Liensinine alleviates sepsis-induced acute liver injury by inhibiting the NF-\u03baB and MAPK pathways in an Nrf2-dependent manner. Chem Biol Interact 396:111030. https:\/\/doi.org\/10.1016\/j.cbi.2024.111030","journal-title":"Chem Biol Interact"},{"key":"5701_CR24","doi-asserted-by":"publisher","first-page":"1583185","DOI":"10.1155\/2017\/1583185","volume":"2017","author":"EJ Kang","year":"2017","unstructured":"Kang EJ, Lee SK, Park K-K et al (2017) Liensinine and Nuciferine, Bioactive Components of Nelumbo nucifera, Inhibit the Growth of Breast Cancer Cells and Breast Cancer-Associated Bone Loss. Evid Based Complement Alternat Med 2017:1583185. https:\/\/doi.org\/10.1155\/2017\/1583185","journal-title":"Evid Based Complement Alternat Med"},{"key":"5701_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cis.2015.04.006","volume":"221","author":"Y Liu","year":"2015","unstructured":"Liu Y, Feng N (2015) Nanocarriers for the delivery of active ingredients and fractions extracted from natural products used in traditional Chinese medicine (TCM). Adv Colloid Interface Sci 221:60\u201376. https:\/\/doi.org\/10.1016\/j.cis.2015.04.006","journal-title":"Adv Colloid Interface Sci"},{"key":"5701_CR26","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, Sasso JM, Wang X et al (2022) ExosomesNature\u2019s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. ACS Nano 16:17802\u201317846. https:\/\/doi.org\/10.1021\/acsnano.2c08774","journal-title":"ACS Nano"},{"key":"5701_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2023.100799","volume":"18","author":"J Zeng","year":"2023","unstructured":"Zeng J, Sun P, Zhao Y et al (2023) Bone mesenchymal stem cell-derived exosomes involved co-delivery and synergism effect with icariin via mussel-inspired multifunctional hydrogel for cartilage protection. Asian J Pharm Sci 18:100799. https:\/\/doi.org\/10.1016\/j.ajps.2023.100799","journal-title":"Asian J Pharm Sci"},{"key":"5701_CR28","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1021\/acs.nanolett.9b00287","volume":"19","author":"H Song","year":"2019","unstructured":"Song H, Li X, Zhao Z et al (2019) Reversal of Osteoporotic Activity by Endothelial Cell-Secreted Bone Targeting and Biocompatible Exosomes. Nano Lett 19:3040\u20133048. https:\/\/doi.org\/10.1021\/acs.nanolett.9b00287","journal-title":"Nano Lett"},{"key":"5701_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092073","volume":"9","author":"J-M Kim","year":"2020","unstructured":"Kim J-M, Lin C, Stavre Z et al (2020) Osteoblast-osteoclast communication and bone homeostasis. Cells 9:2073. https:\/\/doi.org\/10.3390\/cells9092073","journal-title":"Cells"},{"key":"5701_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118141","volume":"329","author":"X Wang","year":"2024","unstructured":"Wang X, Tang P, Yang K et al (2024) Regulation of bone homeostasis by traditional Chinese medicine active scaffolds and enhancement for the osteoporosis bone regeneration. J Ethnopharmacol 329:118141. https:\/\/doi.org\/10.1016\/j.jep.2024.118141","journal-title":"J Ethnopharmacol"},{"key":"5701_CR31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.fmre.2024.03.025","volume":"5","author":"L Li","year":"2025","unstructured":"Li L, Wang F, Zhu D et al (2025) Engineering exosomes and exosome-like nanovesicles for improving tissue targeting and retention. Fundamental Res 5:851\u2013867. https:\/\/doi.org\/10.1016\/j.fmre.2024.03.025","journal-title":"Fundamental Res"},{"key":"5701_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.addr.2012.06.011","volume":"65","author":"JG van den Boorn","year":"2013","unstructured":"van den Boorn JG, Da\u00dfler J, Coch C et al (2013) Exosomes as nucleic acid nanocarriers. Adv Drug Deliv Rev 65:331\u2013335. https:\/\/doi.org\/10.1016\/j.addr.2012.06.011","journal-title":"Adv Drug Deliv Rev"},{"key":"5701_CR33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","volume":"56","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Shin KJ, Chae YC (2024) Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med 56:877\u2013889. https:\/\/doi.org\/10.1038\/s12276-024-01209-y","journal-title":"Exp Mol Med"},{"key":"5701_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112784","volume":"207","author":"M Li","year":"2020","unstructured":"Li M, Li S, Du C et al (2020) Exosomes from different cells: characteristics, modifications, and therapeutic applications. Eur J Med Chem 207:112784. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112784","journal-title":"Eur J Med Chem"},{"key":"5701_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-05671-w","volume":"20","author":"Z Pi","year":"2025","unstructured":"Pi Z, Wu Y, Wang X et al (2025) Exosomal Manf originated from endothelium regulated osteoclast differentiation by down-regulating NF-\u03baB signaling pathway. J Orthop Surg Res 20:349. https:\/\/doi.org\/10.1186\/s13018-025-05671-w","journal-title":"J Orthop Surg Res"},{"key":"5701_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109608","volume":"27","author":"J Wang","year":"2024","unstructured":"Wang J, Xie X, Li H et al (2024) Vascular endothelial cells-derived exosomes synergize with curcumin to prevent osteoporosis development. iScience 27:109608. https:\/\/doi.org\/10.1016\/j.isci.2024.109608","journal-title":"iScience"},{"key":"5701_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101416","volume":"12","author":"H Zeng","year":"2023","unstructured":"Zeng H, Guo S, Ren X et al (2023) Current strategies for exosome cargo loading and targeting delivery. Cells 12:1416. https:\/\/doi.org\/10.3390\/cells12101416","journal-title":"Cells"},{"key":"5701_CR38","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1208\/s12248-017-0154-9","volume":"19","author":"F Aqil","year":"2017","unstructured":"Aqil F, Munagala R, Jeyabalan J et al (2017) Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin. AAPS J 19:1691\u20131702. https:\/\/doi.org\/10.1208\/s12248-017-0154-9","journal-title":"AAPS J"},{"key":"5701_CR39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jconrel.2025.01.029","volume":"379","author":"Z Guo","year":"2025","unstructured":"Guo Z, Zhang Y, Gong Y et al (2025) Antibody functionalized curcuma-derived extracellular vesicles loaded with doxorubicin overcome therapy-induced senescence and enhance chemotherapy. J Controlled Release 379:377\u2013389. https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.029","journal-title":"J Controlled Release"},{"key":"5701_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","volume":"12","author":"MS Kim","year":"2016","unstructured":"Kim MS, Haney MJ, Zhao Y et al (2016) Development of Exosome-encapsulated Paclitaxel to Overcome MDR in Cancer cells. Nanomedicine 12:655\u2013664. https:\/\/doi.org\/10.1016\/j.nano.2015.10.012","journal-title":"Nanomedicine"},{"key":"5701_CR41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jconrel.2022.05.012","volume":"347","author":"H Al Faruque","year":"2022","unstructured":"Al Faruque H, Choi E-S, Kim J-H, Kim E (2022) Enhanced effect of autologous EVs delivering paclitaxel in pancreatic cancer. J Controlled Release 347:330\u2013346. https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.012","journal-title":"J Controlled Release"},{"key":"5701_CR42","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1084\/jem.20040518","volume":"200","author":"T Kukita","year":"2004","unstructured":"Kukita T, Wada N, Kukita A et al (2004) RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis. J Exp Med 200:941\u2013946. https:\/\/doi.org\/10.1084\/jem.20040518","journal-title":"J Exp Med"},{"key":"5701_CR43","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/jbmr.1575","volume":"27","author":"H Miyamoto","year":"2012","unstructured":"Miyamoto H, Suzuki T, Miyauchi Y et al (2012) Osteoclast stimulatory transmembrane protein and dendritic cell\u2013specific transmembrane protein cooperatively modulate cell\u2013cell fusion to form osteoclasts and foreign body giant cells. J Bone Miner Res 27:1289\u20131297. https:\/\/doi.org\/10.1002\/jbmr.1575","journal-title":"J Bone Miner Res"},{"key":"5701_CR44","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/nm1514","volume":"12","author":"S-H Lee","year":"2006","unstructured":"Lee S-H, Rho J, Jeong D et al (2006) v-ATPase V0 subunit d2\u2013deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 12:1403\u20131409. https:\/\/doi.org\/10.1038\/nm1514","journal-title":"Nat Med"},{"key":"5701_CR45","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1359\/jbmr.081239","volume":"24","author":"H Wu","year":"2009","unstructured":"Wu H, Xu G, Li Y-P (2009) Atp6v0d2 Is an Essential Component of the Osteoclast-Specific Proton Pump That Mediates Extracellular Acidification in Bone Resorption. J Bone Miner Res 24:871\u2013885. https:\/\/doi.org\/10.1359\/jbmr.081239","journal-title":"J Bone Miner Res"},{"key":"5701_CR46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.abb.2014.06.017","volume":"558","author":"A Cappariello","year":"2014","unstructured":"Cappariello A, Maurizi A, Veeriah V, Teti A (2014) The Great Beauty of the osteoclast. Arch Biochem Biophys 558:70\u201378. https:\/\/doi.org\/10.1016\/j.abb.2014.06.017","journal-title":"Arch Biochem Biophys"},{"key":"5701_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1749-6632.2011.06283.x","volume":"1240","author":"SL Teitelbaum","year":"2011","unstructured":"Teitelbaum SL (2011) The osteoclast and its unique cytoskeleton. Ann N Y Acad Sci 1240:14\u201317. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06283.x","journal-title":"Ann N Y Acad Sci"},{"key":"5701_CR48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrrheum.2011.77","volume":"7","author":"AG Costa","year":"2011","unstructured":"Costa AG, Cusano NE, Silva BC et al (2011) Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis. Nat Rev Rheumatol 7:447\u2013456. https:\/\/doi.org\/10.1038\/nrrheum.2011.77","journal-title":"Nat Rev Rheumatol"},{"key":"5701_CR49","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fcell.2020.00433","volume":"8","author":"R Dai","year":"2020","unstructured":"Dai R, Wu Z, Chu HY et al (2020) Cathepsin K: The Action in and Beyond Bone. Front Cell Dev Biology 8:433. https:\/\/doi.org\/10.3389\/fcell.2020.00433","journal-title":"Front Cell Dev Biology"},{"key":"5701_CR50","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00223-009-9309-8","volume":"85","author":"AJ Janckila","year":"2009","unstructured":"Janckila AJ, Yam LT (2009) Biology and Clinical Significance of Tartrate-Resistant Acid Phosphatases: New Perspectives on an Old Enzyme. Calcif Tissue Int 85:465\u2013483. https:\/\/doi.org\/10.1007\/s00223-009-9309-8","journal-title":"Calcif Tissue Int"},{"key":"5701_CR51","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrg1122","volume":"4","author":"SL Teitelbaum","year":"2003","unstructured":"Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638\u2013649. https:\/\/doi.org\/10.1038\/nrg1122","journal-title":"Nat Rev Genet"},{"key":"5701_CR52","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.7150\/thno.28391","volume":"8","author":"X Duan","year":"2018","unstructured":"Duan X, Yang S, Zhang L, Yang T (2018) V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis. Theranostics 8:5379\u20135399. https:\/\/doi.org\/10.7150\/thno.28391","journal-title":"Theranostics"},{"key":"5701_CR53","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrm2272","volume":"8","author":"M Forgac","year":"2007","unstructured":"Forgac M (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8:917\u2013929. https:\/\/doi.org\/10.1038\/nrm2272","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5701_CR54","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1359\/jbmr.1999.14.10.1654","volume":"14","author":"M Gowen","year":"1999","unstructured":"Gowen M, Lazner F, Dodds R et al (1999) Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1654\u20131663. https:\/\/doi.org\/10.1359\/jbmr.1999.14.10.1654","journal-title":"J Bone Miner Res"},{"key":"5701_CR55","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1242\/dev.122.10.3151","volume":"122","author":"AR Hayman","year":"1996","unstructured":"Hayman AR, Jones SJ, Boyde A et al (1996) Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122:3151\u20133162. https:\/\/doi.org\/10.1242\/dev.122.10.3151","journal-title":"Development"},{"key":"5701_CR56","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1359\/jbmr.2003.18.10.1905","volume":"18","author":"AR Hayman","year":"2003","unstructured":"Hayman AR, Cox TM (2003) Tartrate-Resistant Acid Phosphatase Knockout Mice. J Bone Miner Res 18:1905\u20131907. https:\/\/doi.org\/10.1359\/jbmr.2003.18.10.1905","journal-title":"J Bone Miner Res"},{"key":"5701_CR57","doi-asserted-by":"publisher","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","volume":"95","author":"P Saftig","year":"1998","unstructured":"Saftig P, Hunziker E, Wehmeyer O et al (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95:13453\u201313458. https:\/\/doi.org\/10.1073\/pnas.95.23.13453","journal-title":"Proc Natl Acad Sci USA"},{"key":"5701_CR58","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1126\/science.7939685","volume":"266","author":"AE Grigoriadis","year":"1994","unstructured":"Grigoriadis AE, Wang Z-Q, Cecchini MG et al (1994) c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling. Science 266:443\u2013448. https:\/\/doi.org\/10.1126\/science.7939685","journal-title":"Science"},{"key":"5701_CR59","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Koga T et al (2002) Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts. Dev Cell 3:889\u2013901. https:\/\/doi.org\/10.1016\/S1534-5807(02)00369-6","journal-title":"Dev Cell"},{"key":"5701_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00788-w","volume":"30","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu Y, Deng Y et al (2024) Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets. Mol Med 30:20. https:\/\/doi.org\/10.1186\/s10020-024-00788-w","journal-title":"Mol Med"},{"key":"5701_CR61","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z et al (2020) Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Sig Transduct Target Ther 5:209. https:\/\/doi.org\/10.1038\/s41392-020-00312-6","journal-title":"Sig Transduct Target Ther"},{"key":"5701_CR62","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1084\/jem.20051150","volume":"202","author":"M Asagiri","year":"2005","unstructured":"Asagiri M, Sato K, Usami T et al (2005) Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 202:1261\u20131269. https:\/\/doi.org\/10.1084\/jem.20051150","journal-title":"J Exp Med"},{"key":"5701_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.0105-2896.2005.00325.x","volume":"208","author":"MB Humphrey","year":"2005","unstructured":"Humphrey MB, Lanier LL, Nakamura MC (2005) Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev 208:50\u201365. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00325.x","journal-title":"Immunol Rev"},{"issue":"6984","key":"5701_CR64","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature02444","volume":"428","author":"T Koga","year":"2004","unstructured":"Koga T, Inui M, Inoue K et al (2004) Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428(6984):758\u2013763. https:\/\/doi.org\/10.1038\/nature02444","journal-title":"Nature"},{"key":"5701_CR65","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","volume":"66","author":"J Liu","year":"1991","unstructured":"Liu J, Farmer JD, Lane WS et al (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807\u2013815. https:\/\/doi.org\/10.1016\/0092-8674(91)90124-H","journal-title":"Cell"},{"key":"5701_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0143-4160(02)00078-7","volume":"32","author":"AA Tokmakov","year":"2002","unstructured":"Tokmakov AA, Sato K-I, Iwasaki T, Fukami Y (2002) Src kinase induces calcium release in xenopus egg extracts via PLCgamma and IP3-dependent mechanism. Cell Calcium 32:11\u201320. https:\/\/doi.org\/10.1016\/s0143-4160(02)00078-7","journal-title":"Cell Calcium"},{"key":"5701_CR67","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s13346-021-01087-1","volume":"12","author":"J He","year":"2022","unstructured":"He J, Ren W, Wang W et al (2022) Exosomal targeting and its potential clinical application. Drug Deliv Transl Res 12:2385\u20132402. https:\/\/doi.org\/10.1007\/s13346-021-01087-1","journal-title":"Drug Deliv Transl Res"},{"key":"5701_CR68","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G Van Niel","year":"2018","unstructured":"Van Niel G, D\u2019Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19:213\u2013228. https:\/\/doi.org\/10.1038\/nrm.2017.125","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5701_CR69","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1113\/JP282053","volume":"601","author":"P Ranjan","year":"2023","unstructured":"Ranjan P, Colin K, Dutta RK, Verma SK (2023) Challenges and future scope of exosomes in the treatment of cardiovascular diseases. J Physiol 601:4873\u20134893. https:\/\/doi.org\/10.1113\/JP282053","journal-title":"J Physiol"},{"key":"5701_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/nano11061481","volume":"11","author":"A Butreddy","year":"2021","unstructured":"Butreddy A, Kommineni N, Dudhipala N (2021) Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives. Nanomaterials (Basel) 11:1481. https:\/\/doi.org\/10.3390\/nano11061481","journal-title":"Nanomaterials (Basel)"},{"key":"5701_CR71","doi-asserted-by":"publisher","unstructured":"Batrakova EV, Kim MS Development and regulation of exosome-based therapy products. https:\/\/doi.org\/10.1002\/wnan.1395","DOI":"10.1002\/wnan.1395"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05701-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05701-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05701-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:45:10Z","timestamp":1791186310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05701-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":71,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5701"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05701-z","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}